cd38 inhibitor and 5-amino-1mq synergy nad+ is a key mediator of depletion in the brain of ZIKV-infected mice: iScience CD38-Induced Metabolic Dysfunction Primes Multiple
CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Targeting NAD+ Synthesis to Potentiate CD38 Based Immunotherapy of Multiple Myeloma ScienceDirect CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link A systems approach to NAD+ restoration ScienceDirect SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism The CD38 glycohydrolase and the NAD sink: implications for pathological conditions American Journal of Physiology Cell Physiology American Physiological Society
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





